CA Stock MarketDetailed Quotes

GUD Knight Therapeutics Inc

Watchlist
  • 5.990
  • 0.0000.00%
15min DelayTrading Apr 30 11:03 ET
596.25MMarket Cap149.75P/E (TTM)

Knight Therapeutics Inc Key Stats

Knight Therapeutics Inc Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 97.531M--
--2025/Q1-- / 87.672M--
Mar 20, 20252024/Q496.864M / 87.621M--
Nov 7, 20242024/Q392.263M / 89.426M--
Aug 8, 20242024/Q295.573M / 87.667M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 97.531M--
--2025/Q1-- / 87.672M--
Mar 20, 20252024/Q496.864M / 87.621M--
Nov 7, 20242024/Q392.263M / 89.426M--
Aug 8, 20242024/Q295.573M / 87.667M--

Unlock Free Earnings Estimates

Knight Therapeutics Inc Earnings Reports

Read more